Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Clinical experience with misonidazole.

S Dische, M I Saunders

    The British Journal of Cancer. Supplement
    |June 1, 1978
    PubMed
    Summary
    This summary is machine-generated.

    Researchers investigated the safe dosage and effectiveness of misonidazole combined with radiotherapy for advanced tumors. While normal tissue reactions were not increased, a promising enhanced tumor response was observed.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    To restore coastal marine areas, we need to work across multiple habitats simultaneously.

    Proceedings of the National Academy of Sciences of the United States of America·2023
    Same author

    Abstracts from the 8th Annual Meeting of the Scientific Association of Swiss Radiation Oncology (SASRO).

    Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]·2016
    Same author

    Impact of sea-level rise and coral mortality on the wave dynamics and wave forces on barrier reefs.

    Marine pollution bulletin·2014
    Same author

    Phase Ib trial of radiotherapy in combination with combretastatin-A4-phosphate in patients with non-small-cell lung cancer, prostate adenocarcinoma, and squamous cell carcinoma of the head and neck.

    Annals of oncology : official journal of the European Society for Medical Oncology·2011
    Same author

    Adaptive 18fluoro-2-deoxyglucose positron emission tomography/computed tomography-based target volume delineation in radiotherapy planning of head and neck cancer.

    Clinical oncology (Royal College of Radiologists (Great Britain))·2010
    Same author

    Carbogen breathing increases prostate cancer oxygenation: a translational MRI study in murine xenografts and humans.

    British journal of cancer·2009
    Same journal

    The proceedings of the Cancer Research Campaign/Department of Health Symposium on Ethnic Minorities and Cancer.

    The British journal of cancer. Supplement·1996
    Same journal

    Smoking cessation programmes targeted at black and minority ethnic communities.

    The British journal of cancer. Supplement·1996
    Same journal

    Betel-quid and tobacco chewing among the United Kingdom's Bangladeshi community.

    The British journal of cancer. Supplement·1996
    Same journal

    Ethnicity and health beliefs with respect to cancer: a critical review of methodology.

    The British journal of cancer. Supplement·1996
    Same journal

    Eliciting lay beliefs across cultures: principles and methodology.

    The British journal of cancer. Supplement·1996
    Same journal

    Cancer clinical outcomes for minority ethnic groups.

    The British journal of cancer. Supplement·1996
    See all related articles

    Area of Science:

    • Oncology
    • Radiotherapy
    • Pharmacology

    Background:

    • Advanced tumors present significant treatment challenges.
    • Radiotherapy is a cornerstone of cancer treatment.
    • Misonidazole is an investigational hypoxic cell radiosensitizer.

    Purpose of the Study:

    • To determine safe dosage and suitable regimens for misonidazole in clinical radiotherapy.
    • To evaluate the impact of misonidazole on normal tissue reactions.
    • To assess the potential for enhanced tumor response when combining misonidazole with radiotherapy.

    Main Methods:

    • Fractionated radiotherapy course administered to 62 patients with advanced tumors.
    • Co-administration of misonidazole to assess safety and efficacy.
    • Monitoring of normal tissue reactions and tumor response.

    Related Experiment Videos

    Main Results:

    • Safe dosage and suitable regimens for misonidazole were identified.
    • No significant enhancement in normal tissue reactions was observed.
    • An impression of increased tumor response was noted.

    Conclusions:

    • Misonidazole can be safely administered with fractionated radiotherapy.
    • The combination shows potential for improved tumor control without increased normal tissue toxicity.
    • Further investigation into enhanced tumor response is warranted.